Aptose Biosciences Sold Out: Insider Exodus Marks End of Public Chapter After Hanmi Takeover Flash
Whitehead Warren’s final Aptose Biosciences sale marks the end of the company’s public life as Hanmi Pharmaceutical absorbs its oncology pipeline and delists the stock.
7 minutes to read